Abstract
Objective: To develop estimates of the direct and indirect costs of smoking for California in 1999.
Methods: A prevalence based approach was used to estimate the annual costs of smoking. Econometric models were used to estimate the smoking attributable fraction (SAF) for direct costs (hospitalisations, ambulatory care, prescription drugs, home health care, and nursing home services) and indirect costs due to lost productivity from smoking related illness. The models controlled for socioeconomic factors and other risk behaviours. Epidemiological methods were used to estimate the SAF for indirect costs due to lost productivity from premature deaths. The SAFs were applied to total health care expenditures, days lost, and deaths to obtain smoking attributable total costs.
Results: In 1999, the total costs of smoking in California were $15.9 billion, $475 per resident, and $3331 per smoker. Direct costs were $8.6 billion (54% of the total), indirect costs due to lost productivity from illness were $1.5 billion (10%), and indirect costs due to premature deaths were $5.7 billion (36%). The cost of smoking was $9.4 billion for men and $6.3 billion for women. There were 43 137 deaths attributed to smoking, representing a total of 535 000 years of life lost. The value of life lost per death averaged $132 000, or 12.4 years.
Conclusions: California smoking related costs are high. The cost methodology presented is useful for other states and nations interested in estimating their costs of smoking. Cost estimates can be used to evaluate the level of cigarette taxes and other policies related to smoking.
Full Text
The Full Text of this article is available as a PDF (68.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Centers for Disease Control and Prevention (CDC) Medical-care expenditures attributable to cigarette smoking--United States, 1993. MMWR Morb Mortal Wkly Rep. 1994 Jul 8;43(26):469–472. [PubMed] [Google Scholar]
- Gruber Jonathan. The economics of tobacco regulation. Health Aff (Millwood) 2002 Mar-Apr;21(2):146–162. doi: 10.1377/hlthaff.21.2.146. [DOI] [PubMed] [Google Scholar]
- Martin A. B., Whittle L. S., Levit K. R. Trends in state health care expenditures and funding: 1980-1998. Health Care Financ Rev. 2001 Summer;22(4):111–140. [PMC free article] [PubMed] [Google Scholar]
- McGinnis J. M., Foege W. H. Actual causes of death in the United States. JAMA. 1993 Nov 10;270(18):2207–2212. [PubMed] [Google Scholar]
- Miller L. S., Zhang X., Novotny T., Rice D. P., Max W. State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993. Public Health Rep. 1998 Mar-Apr;113(2):140–151. [PMC free article] [PubMed] [Google Scholar]
- Miller L. S., Zhang X., Rice D. P., Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep. 1998 Sep-Oct;113(5):447–458. [PMC free article] [PubMed] [Google Scholar]
- Miller V. P., Ernst C., Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med. 1999 Feb;48(3):375–391. doi: 10.1016/s0277-9536(98)00344-x. [DOI] [PubMed] [Google Scholar]
- Warner K. E., Hodgson T. A., Carroll C. E. Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control. 1999 Autumn;8(3):290–300. doi: 10.1136/tc.8.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang X., Miller L., Max W., Rice D. P. Cost of smoking to the Medicare program, 1993. Health Care Financ Rev. 1999 Summer;20(4):179–196. [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.